Legend Biotech
LEGN
LEGN
157 hedge funds and large institutions have $2.64B invested in Legend Biotech in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 79 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.08% more ownership
Funds ownership: 17.08% → 20.16% (+3.1%)
8% less capital invested
Capital invested by funds: $2.87B → $2.64B (-$231M)
43% less funds holding in top 10
Funds holding in top 10: 7 → 4 (-3)
Holders
157
Holding in Top 10
4
Calls
$47.1M
Puts
$10.7M
Top Buyers
| 1 | +$241M | |
| 2 | +$148M | |
| 3 | +$95.4M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$34.7M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$33.1M |
Top Sellers
| 1 | -$55M | |
| 2 | -$49.4M | |
| 3 | -$47.1M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$42.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$39M |